HomeNewsNovartis pharma ag

Novartis Pharma Ag

Jump to

Sun Pharma up 3% on 14 prescription brands acquisition in Japan

"A wholly-owned subsidiary of Sun Pharma will acquire portfolio consisting of 14 established prescription brands from Novartis for a cash consideration of USD 293 million," says the company.
India needs predictable IPR regime: Novartis

Novartis India, Managing Director and Vice Chairman, Ranjit Shahani says they want to go from Make in India to invent in India because any economy which needs to be successful, the core has to be innovation.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Novartis Pharma Ag

Sun Pharma up 3% on 14 prescription brands acquisition in Japan

India needs predictable IPR regime: Novartis